Nothing Special   »   [go: up one dir, main page]

ATE345354T1 - Methode zur identifizierung von helicobacter antigenen - Google Patents

Methode zur identifizierung von helicobacter antigenen

Info

Publication number
ATE345354T1
ATE345354T1 AT01931657T AT01931657T ATE345354T1 AT E345354 T1 ATE345354 T1 AT E345354T1 AT 01931657 T AT01931657 T AT 01931657T AT 01931657 T AT01931657 T AT 01931657T AT E345354 T1 ATE345354 T1 AT E345354T1
Authority
AT
Austria
Prior art keywords
helicobacter
helicobacter antigens
antigens
identifying helicobacter
identifying
Prior art date
Application number
AT01931657T
Other languages
English (en)
Inventor
Thomas F Meyer
Peter Jungblut
Dirk Bumann
Anton Aebischer
Gaby Haas
Ursula Zimny-Arndt
Stephanie Lamer
Galip Karaali
Nicolas Sabarth
Meike Wendland
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE345354T1 publication Critical patent/ATE345354T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01931657T 2000-04-27 2001-04-26 Methode zur identifizierung von helicobacter antigenen ATE345354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108968 2000-04-27
EP01101439 2001-01-23

Publications (1)

Publication Number Publication Date
ATE345354T1 true ATE345354T1 (de) 2006-12-15

Family

ID=26070866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931657T ATE345354T1 (de) 2000-04-27 2001-04-26 Methode zur identifizierung von helicobacter antigenen

Country Status (6)

Country Link
US (1) US20030180330A1 (de)
EP (1) EP1278768B1 (de)
AT (1) ATE345354T1 (de)
AU (1) AU2001258373A1 (de)
DE (1) DE60124526D1 (de)
WO (1) WO2001083531A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
EP0909272B1 (de) * 1996-06-10 2007-02-07 Borén, Thomas Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
ATE434185T1 (de) * 2000-05-18 2009-07-15 Meridian Bioscience Inc Immunoassay für h. pylori in fäkalienproben mit hilfe von gattungsspezifischen antikörpern
CA2414846A1 (en) * 2000-07-05 2002-01-24 Merieux Oravax Immunological combinations for prophylaxis and therapy of helicobacter pylori infection
CA2351110A1 (en) * 2000-07-17 2002-01-17 Akzo Nobel N.V. Helicobacter felis vaccine
US20030013138A1 (en) * 2001-05-29 2003-01-16 The Regents Of The University Of Michigan Systems and methods for the analysis of proteins
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
EP1837345A1 (de) * 2006-03-23 2007-09-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pharmazeutische Zusammensetzungen, die Cholesteryl-alpha-glukosyltransferase zur Behandlung von Helicobacter pylori Infektionen enthalten
BR112016030728A2 (pt) * 2014-06-30 2018-02-20 Murdoch Childrens Research Institute método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença
CA3007036A1 (en) 2015-12-14 2017-06-22 Technische Universitat Munchen Helicobacter pylori vaccines
EP3272354A1 (de) 2016-07-20 2018-01-24 Technische Universität München Wirkstoffe und verfahren zur vorbeugung oder behandlung von h.-pylori-infektionen
CN111793137A (zh) * 2019-12-12 2020-10-20 南京蛋球球生物医学技术合伙企业(有限合伙) 一种Hp四价抗原及其制备方法与应用
JP6867529B1 (ja) * 2020-03-16 2021-04-28 栄研化学株式会社 ヘリコバクター・ピロリ検出用抗体
CN114907491B (zh) * 2022-06-21 2023-06-16 中国科学院西北生态环境资源研究院 一种多表位肽、幽门螺旋杆菌八价多表位疫苗及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US52799A (en) * 1866-02-20 Improved apparatus for driving metal or wood into the ground
US160456A (en) * 1875-03-02 Improvement in locomotive spark-arresters
US115078A (en) * 1871-05-23 Improvement in whiffletrees
US158396A (en) * 1875-01-05 Improvement in street-lamps
JPH10502366A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
JP4368944B2 (ja) * 1995-04-21 2009-11-18 シーエスエル、リミテッド 防御用ヘリコバクター抗原
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
EP0835928A1 (de) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Helicobacter Pylori Lebendimpfstoff
US20040052799A1 (en) * 1996-11-15 2004-03-18 Astra Aktiebolag Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
WO1998043478A1 (en) * 1997-04-01 1998-10-08 Merieux Oravax Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
WO1998049314A2 (en) * 1997-04-25 1998-11-05 Genelabs Technologies, Inc. ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI)
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism

Also Published As

Publication number Publication date
WO2001083531A1 (en) 2001-11-08
AU2001258373A1 (en) 2001-11-12
EP1278768B1 (de) 2006-11-15
EP1278768A1 (de) 2003-01-29
US20030180330A1 (en) 2003-09-25
DE60124526D1 (de) 2006-12-28

Similar Documents

Publication Publication Date Title
ATE345354T1 (de) Methode zur identifizierung von helicobacter antigenen
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
BR0008188A (pt) Inibidores de fator de diferenciação de crescimento e usos para os mesmos
EA200600591A1 (ru) МОДУЛИРОВАНИЕ ЭКСПРЕССИИ eIF4E
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
HUP0303738A2 (hu) Új peszticid toxinok
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
IL166021A0 (en) Trabsolant acceptance inducing cells of monocytic origin and their preparation and use
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
FR2827866B1 (fr) Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
ATE318134T1 (de) Methode zur herstellung lycopen-konzentrats frei von organischen lösungsmitteln, das resultierende konzentrat und dieses konzentrat enthaltende zusammensetzungen
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
DE60139544D1 (de) Veränderte, fluoreszierende proteine
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
DE69923559D1 (de) Methoden zur inhibierung von helicobacter pylori
DE60107718D1 (de) Konservierung von zellen
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
WO2001096873A3 (en) Method for identifying apoptosis-modified proteins
EA200400751A1 (ru) Применение дезоксипеганина для лечения клинической депрессии
ATE359815T1 (de) Streptococcus-phocae-vakzine
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
NO20051301L (no) Proteintyrosinforfataseinhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties